5L2T | Transferase Transferase Inhibitor | date | Aug 02, 2016 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | The X-Ray Co-Crystal Structure Of Human Cdk6 And Ribociclib. | ||||||||||||||
authors | P.Chen, R.A.Ferre, W.Deihl, X.Yu, Y.A.He | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Cyclin-Dependent Kinase 6 Chain: A Fragment: Unp Residues 1-301 Synonym: Cell Division Protein Kinase 6,Serinethreonine-Pr Kinase Plstire; Ec: 2.7.11.22 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Cdk6, Cdkn6 Expression_system: Spodoptera Frugiperda Expression_system_taxid: 7108 | ||||||||||||||
symmetry | Space Group: I 4 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.37 Å | ||||||||||||
ligand | 6ZZ | enzyme | Transferase E.C.2.7.11.22 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance., Chen P, Lee N, Hu W, Xu M, Ferre RA, Lam H, Bergqvist S, Solowiej J, Diehl W, He YA, Yu X, Nagata A, VanArsdale T, Murray BW, Mol Cancer Ther. 2016 Aug 5. pii: molcanther.0300.2016. PMID:27496135 |
Data retrieval |
View 5L2T in 3D |
Visual 3D analysis of 5L2T |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5L2T |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |